v3.25.2
Interim Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Net revenues
Operating expenses:    
Product research and development 277,364 301,617
Legal and accounting 186,811 258,831
Consulting 95,204 120,479
Filing fees 15,022 27,372
Bad debts 520
Other 24,981 29,272
Total operating expenses 599,382 738,091
Operating loss (599,382) (738,091)
Loss before provision for income taxes (599,382) (738,091)
Provision (benefit) for income taxes
Net loss (599,382) (738,091)
Other Comprehensive Income (Loss):    
Currency Translation Adjustment 2,074 (587)
Comprehensive loss $ (597,308) $ (738,678)
Weighted average shares outstanding:    
Basic (in Shares) 13,875,000 13,478,533
Diluted (in Shares) 13,875,000 13,478,533
Weighted average net loss per share:    
Basic (in Dollars per share) $ (0.04) $ (0.05)
Diluted (in Dollars per share) $ (0.04) $ (0.05)
Capital Shares    
Weighted average shares outstanding:    
Basic (in Shares)
Diluted (in Shares)